7th Oct 2014 17:31
LONDON (Alliance News) - GlaxoSmithKline PLC Friday said that Chief ExecuitvE Officer Andrew Witty and the following directors and managers in the company acquired shares on Monday via a re-investment of dividends, at a price of 1140.375 pence per share.
Director/PDMR |
Number of Ordinary shares |
Sir Andrew Witty |
108 |
Mr D S Redfern |
20 |
Mrs V A Whyte |
17 |
Connected person |
Number of Ordinary shares |
Lady C Witty |
21 |
Shares in the pharmaceuticals giant closed 1.6% lower Tuesday at 1,411.54 pence.
By Rowena Harris-Doughty; [email protected]; @rharrisdoughty
Copyright 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Glaxosmithkline